427 results on '"Quach C"'
Search Results
2. Automatic Interpretation of Unordered Point Cloud Data for UAV Navigation in Construction
3. Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial
4. Enteropathogens in paediatric gastroenteritis: comparison of routine diagnostic and molecular methods
5. Optimizing Patient-Centered Inclusive Care in Oncology: Healthcare Professionals' Knowledge, Attitudes and Practices Caring for LGBTQ2+ Individuals
6. Démences du sujet jeune : particularités étiologiques, apport de l’IRM
7. Early-onset dementias: Specific etiologies and contribution of MRI
8. Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses
9. Impact of the COVID-19 pandemic on maternal mental health during pregnancy: The CONCEPTION study – Phase I
10. Hand hygiene compliance in the prevention of hospital-acquired infections: a systematic review
11. Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: Protocol for a cohort study in Montreal, Canada
12. Measuring antimicrobial use in hospitalized patients: a systematic review of available measures applicable to paediatrics
13. Patient-reported outcomes (PROs) from IMvigor130: A global, randomised, partially blinded phase III study of atezolizumab (atezo) plus platinum-based chemotherapy (PBC) vs placebo (PBO) plus PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)
14. 698O Patient-reported outcomes (PROs) from IMvigor130: A global, randomised, partially blinded phase III study of atezolizumab (atezo) + platinum-based chemotherapy (PBC) vs placebo (PBO) + PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)
15. PMU47 NOSOCOMIAL INFLUENZA HOSPITALIZATIONS AMONG END-STAGE RENAL DISEASE PATIENTS DURING THE 2013-2014 THROUGH 2015-2016 INFLUENZA SEASONS
16. PCN180 EQ-5D UTILITY ESTIMATES FROM THE IMPOWER 133 TRIAL OF TECENTRIQ + CARBOPLATIN + ETOPOSIDE VS. CARBOPLATIN + ETOPOSIDE IN FIRST LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
17. Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination
18. In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae
19. Épidémiologie de l’infection à Clostridioides difficile au Canada : revue de six ans de données en appui au processus décisionnel quant à l’utilisation des vaccins
20. Epidemiology of Clostridioides difficile infection in Canada: A six-year review to support vaccine decision-making
21. IMpower133: Patient-reported outcomes (PROs) in a ph1/3 study of first-line (1L) atezolizumab (atezo) + carboplatin + etoposide (CP/ET) in extensive-stage SCLC (ES-SCLC)
22. Rotavirus: the guard dies, but it does not surrender
23. Clinical characteristics of pediatric pertussis cases, Quebec 2015–2017
24. Caractéristiques cliniques des cas pédiatriques de coqueluche au Québec, 2015 à 2017
25. Should equivocal Bordetella pertussis PCR results in children be reported to public health?
26. Les résultats équivoques de la détection par PCR de Bordetella pertussis chez les enfants devraient-ils être signalés aux autorités de la santé publique?
27. Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit
28. Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009–15
29. Automatic interpretation of unordered point cloud data for UAV navigation in construction
30. Epidemiology of infection in Canada: A six-year review to support vaccine decision-making.
31. Rotavirus: the guard dies, but it does not surrender.
32. 49O - IMpower133: Patient-reported outcomes (PROs) in a ph1/3 study of first-line (1L) atezolizumab (atezo) + carboplatin + etoposide (CP/ET) in extensive-stage SCLC (ES-SCLC)
33. 18: Perceived Utility of Respiratory Virus Testing for Febrile Infants Under Six-Weeks of Age Among Canadian Pediatric Emergency and Inpatient Physicians
34. 25: Determinants of Oral Corticosteroid Responsiveness in Wheezing Asthmatic Youth (Doorway)
35. Measurement properties of the lower extremity functional scale: a systematic review
36. 119 3-Bromopyruvate as an inducer of immunogenic cell death in colon cancer cells
37. 151: Rotavirus Vaccination in Neonatal Intensive Care Units: Safety and Feasibility
38. 207: Emergency Department and Inpatient Management of Febrile Infants Under Six-Weeks of Age: Perceived Utility of Respiratory Virus Testing
39. Impact of Colorectal Cancer on Activities of Daily Living and Depression Risk Among Older Americans
40. Determinants Of Oral corticosteroid Responsiveness in Wheezing Asthmatic Youth (DOORWAY): protocol for a prospective multicentre cohort study of children with acute moderate-to-severe asthma exacerbations
41. Pediatric Pleural Empyema in the Province of Quebec: Analysis of a 10-Fold Increase Between 1990 and 2007
42. FRI0528 Using a validated algorithm to evaluate the effectiveness and cost per effectively treated patient for biologics for rheumatoid arthritis (RA) in patients with employer provided health insurance
43. Salmonella enterica serotype Typhi infections in a Canadian pediatric hospital: a retrospective case series
44. Effectiveness And Cost Per Responder With First-Line Biologics For Rheumatoid Arthritis Using A Validated, Claims-Based Algorithm In A Large Us Commercial Health Plan
45. Effectiveness Of Second Line Biologic Use In Rheumatoid Arthritis After Switching From First-Line Biologics
46. Using A Validated Algorithm To Evaluate The Effectiveness Of Biologics For Rheumatoid Arthritis In A Commercial Claims Database
47. Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre
48. Central Line-Associated Bloodstream Infections in Neonatal Intensive Care Units
49. Optimizing battery life for electric UAVs using a Bayesian framework
50. Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.